CDF
Three new entries to Cancer Drugs Fund
February 5, 2014Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo
Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …
Cancer Drugs Fund: assessing a difficult legacy
February 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty
England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …
The CDF: friend and foe?
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low
Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …
SMC must be ‘more flexible’ – health minister
October 9, 2013Sales and Marketing CDF, NICE, SMC
The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …
Cancer survival rates linked to government spending in EU
October 1, 2013Research and Development, Sales and Marketing CDF, Cancer, EU, NICE
The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …
Cancer Drugs Fund to run until 2016
September 30, 2013Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP
England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …
Cancer Drugs Fund to stay, government to announce
September 27, 2013Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister
The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …
‘Inequality’ for Welsh cancer patients
August 28, 2013Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales
Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …
David Haslam: a new chairman for a new NICE
June 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE
When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …
Sanofi cleared in sales row
September 20, 2012Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi
Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …
Cancer Drugs Fund ‘the wrong choice’ for Wales
May 29, 2012Sales and Marketing CDF, Cancer, NHS, Wales, Welsh
The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …
Government to speed up access to new cancer drugs
April 24, 2012Sales and Marketing CDF, Cancer, Roche, UK, avastin, government, sha
Access to England’s Cancer Drugs Fund will be speeded up, ministers have confirmed. Currently, it can take a number of …
Roche’s melanoma pill launched in UK
March 14, 2012Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf
Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer. Zelboraf (vemurafenib) is the …
Cancer Drugs Fund should not be used across the UK
March 7, 2012Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate
The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …
Zytiga approved in Wales – for now
February 21, 2012Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga
Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …
